{
    "organizations": [],
    "uuid": "27fbbb4bf7dedfdeb64443ae8d3b7dec750de0e4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-klaria-pharma-q4-pre-tax-loss-wide/brief-klaria-pharma-q4-pre-tax-loss-widesn-to-sek-4-2-million-idUSFWN1QI0EQ",
    "ord_in_thread": 0,
    "title": "BRIEF-Klaria Pharma Q4 Pre-Tax Loss Widesn To Sek ‍4.2​ Million",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 28 (Reuters) - Klaria Pharma Holding Ab (Publ) :\n* Q4 PRE-TAX LOSS SEK ‍4.2​ MILLION VERSUS LOSS SEK 3.0 MILLION YEAR AGO\n* ‍BOARD PROPOSES NO DIVIDEND​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-28T15:41:00.000+02:00",
    "crawled": "2018-03-01T21:32:51.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "klaria",
        "pharma",
        "holding",
        "ab",
        "publ",
        "q4",
        "loss",
        "sek",
        "million",
        "versus",
        "loss",
        "sek",
        "million",
        "year",
        "ago",
        "proposes",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}